Xylem Inc. (NYSE:XYL) Given Consensus Recommendation of “Moderate Buy” by Analysts

Xylem Inc. (NYSE:XYL) has been assigned a consensus rating of “Moderate Buy” from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $167.40.

XYL has been the subject of a number of research reports. Citigroup increased their price target on shares of Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a report on Wednesday, October 29th. Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a research report on Monday, December 15th. Stifel Nicolaus boosted their price target on Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Wall Street Zen downgraded Xylem from a “buy” rating to a “hold” rating in a research report on Saturday. Finally, TD Cowen lifted their price objective on Xylem from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Friday, December 5th.

Xylem Trading Down 0.3%

Xylem stock opened at $138.42 on Tuesday. Xylem has a 52 week low of $100.47 and a 52 week high of $154.27. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.50 and a current ratio of 1.96. The firm has a market capitalization of $33.70 billion, a PE ratio of 35.58, a PEG ratio of 2.15 and a beta of 1.18. The business’s 50-day simple moving average is $143.03 and its 200-day simple moving average is $140.02.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Equities research analysts forecast that Xylem will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend was Tuesday, November 25th. Xylem’s payout ratio is presently 41.13%.

Insider Activity at Xylem

In related news, EVP Claudia S. Toussaint sold 10,421 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. The trade was a 25.01% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total value of $251,838.00. Following the completion of the sale, the director owned 16,875 shares in the company, valued at $2,499,862.50. This trade represents a 9.15% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Xylem

Institutional investors and hedge funds have recently made changes to their positions in the company. Mirova lifted its holdings in Xylem by 5.5% during the 3rd quarter. Mirova now owns 152,210 shares of the industrial products company’s stock valued at $22,451,000 after purchasing an additional 7,942 shares during the last quarter. AIA Group Ltd grew its stake in Xylem by 335.1% during the third quarter. AIA Group Ltd now owns 7,440 shares of the industrial products company’s stock worth $1,097,000 after buying an additional 5,730 shares during the last quarter. Keel Point LLC increased its holdings in shares of Xylem by 4.6% during the third quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock worth $263,000 after buying an additional 79 shares in the last quarter. Allworth Financial LP raised its stake in shares of Xylem by 6.8% in the third quarter. Allworth Financial LP now owns 2,405 shares of the industrial products company’s stock valued at $355,000 after acquiring an additional 154 shares during the last quarter. Finally, Swiss Life Asset Management Ltd raised its stake in shares of Xylem by 7.5% in the third quarter. Swiss Life Asset Management Ltd now owns 139,732 shares of the industrial products company’s stock valued at $20,610,000 after acquiring an additional 9,800 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.